PDS BIOTECHNOLOGY CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.365 USD | +2.91% |
|
+13.07% | -31.98% |
| 03-28 | B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating | MT |
| 03-27 | Empire Metals targets key milestones in Australia | AN |
Chart calendar PDS Biotechnology Corporation
393ad7ae36407ae4e0ea8a7e58c929.PRNawZxruj9wdn4NN06gV9LRkPV6sNjHO_4tUEnr58o.SXETk89dl14jHTp7YC2TILyU-5cO_u7qXLBCIh6tuJlqWTOQqTrzbhU-CQ~a11c49512bbe23d80bce92578d87f8ca
Upcoming events on PDS Biotechnology Corporation
Past events on PDS Biotechnology Corporation
| 27/03/2024 12:00 | Q4 2023 Earnings Call |
| 27/03/2024 11:30 | Q4 2023 Earnings Release |
| 18/01/2024 15:00 | B. Riley Securities Oncology Conference |
| 04/12/2023 | Noble Capital Markets Emerging Growth Equity Conference |
| 14/11/2023 13:00 | Q3 2023 Earnings Call |
| 14/11/2023 12:30 | Q3 2023 Earnings Release |
| 19/10/2023 | European Society for Medical Oncology Congress - Abstract Number : 6982 |
| 18/10/2023 08:00 | International Cytokine and Interferon Society Meeting - Ravi A. Madan |
| 04/10/2023 19:00 | LD Micro Main Conference |
| 04/10/2023 19:00 | LD Micro Main Conference |
| 03/10/2023 13:00 | Investor Meeting - Key Opinion Leader |
| 01/10/2023 16:00 | American Society for Radiation Oncology Meeting - Abstract Number #: 55593 |
| 26/09/2023 19:45 | Cantor Global Healthcare Conference - Panel |
| 19/09/2023 13:10 | European Scientific Working Group on Influenza Conference - James Allen |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 14/08/2023 13:00 | Q2 2023 Earnings Call |
| 14/08/2023 12:30 | Q2 2023 Earnings Release |
| 08/08/2023 16:30 | BTIG Biotechnology Conference |
| 14/07/2023 14:00 | Annual General Meeting |
| 06/06/2023 13:00 | American Society of Clinical Oncology Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -20,9 -20,4 -2.63% | -14,9 -15,0 0.67% | -21,4 -22,4 4.14% | -41,7 -31,2 -33.46% | -43,0 -44,2 2.74% | -51,0 |
|
EBIT Million USD | Released Forecast Spread | -21,0 -20,4 -3.11% | -14,9 -14,9 0.28% | -21,4 -22,0 2.58% | -41,7 -30,9 -35.01% | -43,0 -44,9 4.16% | -51,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -14,8 -15,0 1.09% | -21,4 -22,4 4.32% | -42,1 -31,4 -34.09% | -44,3 -46,3 4.19% | -49,4 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -14,8 -14,9 0.09% | -16,9 -19,3 12.36% | -40,9 -30,3 -35% | -42,9 -44,8 4.08% | -51,0 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -0,89 -0,84 -6.59% | -0,66 -0,71 6.6% | -1,43 -1,08 -32.06% | -1,39 -1,45 4.23% | -1,49 |
| Announcement Date | 27/03/20 | 18/03/21 | 31/03/22 | 28/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -6,32 -7,25 12.82% | -8,48 -6,15 -37.87% | -7,09 -9,00 21.19% | -7,28 -8,15 10.68% | -18,8 -8,40 -124.06% | -9,42 -8,30 -13.49% | -12,7 -8,70 -45.88% | -10,5 -13,9 24.35% | -10,4 -13,1 20.36% | -11,1 | -12,5 | -13,3 | -14,1 |
|
EBIT Million USD | Released Forecast Spread | -6,32 -8,44 25.1% | -8,48 -6,56 -29.21% | -7,09 -8,38 15.36% | -7,28 -8,14 10.53% | -18,8 -8,01 -135.04% | -9,42 -9,16 -2.81% | -12,7 -10,2 -24.62% | -10,5 -14,0 24.98% | -10,4 -12,4 16.29% | -11,4 | -11,8 | -12,6 | -13,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,32 -7,30 13.42% | -8,47 -7,05 -20.2% | -7,02 -8,70 19.33% | -7,42 -8,41 11.75% | -19,1 -8,43 -126.92% | -9,66 -9,05 -6.74% | -12,9 -10,1 -27.92% | -10,8 -14,3 24.13% | -10,9 -12,9 15.19% | -11,6 | -12,0 | -12,7 | -13,1 |
|
Net income Million USD | Released Forecast Spread | -6,32 -6,90 8.4% | -8,47 -6,56 -29.13% | -5,82 -7,46 22% | -7,42 -8,21 9.53% | -19,1 -8,54 -124.22% | -9,66 -9,39 -2.84% | -11,5 -10,5 -9.88% | -10,8 -14,6 25.78% | -10,9 -12,7 14.41% | -11,8 | -12,0 | -13,2 | -14,1 |
|
EPS USD | Released Forecast Spread | -0,23 -0,24 4.83% | -0,32 -0,23 -36.75% | -0,20 -0,28 28.99% | -0,26 -0,28 7.61% | -0,67 -0,29 -133.34% | -0,32 -0,31 -4.67% | -0,37 -0,34 -8.82% | -0,35 -0,45 21.47% | -0,35 -0,41 14.63% | -0,37 | -0,36 | -0,38 | -0,38 |
| Announcement Date | 31/03/22 | 11/05/22 | 08/08/22 | 14/11/22 | 28/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 27/03/24 | - | - | - | - |
More events
Past sector events for PDS Biotechnology Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PDSB Stock
- Calendar PDS Biotechnology Corporation
